<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          Global EditionASIA 中文雙語Fran?ais
          Business
          Home / Business / Companies

          Online pharmacies may list abroad

          By Zheng Yiran | China Daily | Updated: 2018-10-22 10:26
          Share
          Share - WeChat
          A visitor reads a brochure at the Ping An Good Doctor's booth during the World Artificial Intelligence Conference in Shanghai on Sept 21. [Photo provided to China Daily]

          111 Inc's Nasdaq IPO, Ping An Health Cloud's float in Hong Kong likely to spark a trend

          111 Inc, China's largest online pharmacy and healthcare service provider that started trading its American Depositary Shares on the Nasdaq stock market in September, is expected to inspire other firms to list overseas or in Hong Kong, market insiders said.

          Many popular online pharmacies in China are subsidiaries of established listed pharmaceutical companies. For instance, 360Kad belongs to Taiantang Pharmaceutical Co Ltd, Ehaoyao is from the Jointown Pharmaceutical Group, and Kede is under Conba Group.

          Market insiders said online pharmacies began as startups, so are preparing to list in the near future to raise funds for their planned expansion and diversification, and to create an exit route for existing investors.

          On Sept 12, 111 Inc raised $100 million from 8.25 million ADS at $14 apiece, at the lower end of the $14-$16 range. However, the amount raised was lower than $148.8 million it targeted from the planned issuance of 9.3 million ADS.

          "Floating on Nasdaq is both a milestone and a starting point for 111 Inc, and our mission is much bigger than public listing on the stock market," said Yu Gang, co-founder and executive chairman of 111 Inc.

          Yu told media that the high standards and transparency of Nasdaq would push the company toward greatness.

          Many online pharmacies have already raised multiple rounds of financing; investors need to withdraw, and listing is inevitable, said Zhang Yibing, general manager of AKang Pharmacy, in an interview to Healthpoint, a network of healthcare and related services.

          After online drugstore Jianke raised $50 million in its A round, its CEO Xie Fangmin said: "The company is well-prepared to list in the United States. We estimate to start trading on the Nasdaq stock market in the coming two to three years, and the company will possibly list on other main boards (as well)."

          Zou Yuming, former executive director of JP Morgan, was appointed senior vice-president of Jianke, sparking speculation that the company may be preparing to list.

          Chen Qiaoshan, a medical analyst at Beijing-based market consultancy Analysys, said: "Online pharmacies have a clear profit model. Currently, the government has favorable policies for them, in that the nation allows prescription drugs to be sold online.

          "Being listed on the market is beneficial to these online companies' development, no matter they want to extend offline pharmacy or cooperate with physical hospitals."

          Wang Yanxiong, founder of 360Kad, told Healthpoint that companies are also inspired by Ping An Health Cloud Co Ltd, an online pharmacy that listed in Hong Kong in May. Its estimated market value reached tens of billion yuan.

          Online pharmacies and Ping An Health Cloud are seen as being under the same healthcare umbrella.

          After listing in Hong Kong, sales revenues of Ping An Health Cloud reached 1.12 billion yuan ($162 million) in the first half of this year, according to its financial report. The health business was its fastest-growing section, yielding 628 million yuan in sales, over half of the total.

          According to the prospectus of 111 Inc, the company's sales revenue last year was 960 million yuan, and that of the first half of this year reached 731 million yuan.

          However, the company is still reeling from losses. In 2017, the company's net loss narrowed by 31 percent to 249 million yuan, and that of the first six months of this year was 129 million yuan.

          In 2017, the business-to-customer or B2C section of 111 Inc was valued at 862 million yuan, while the business-to-business or B2B side was valued at 86.89 million yuan. Although running for only over a year, its B2B business is growing rapidly, with the sales revenue reaching 317 million yuan in the first half of this year.

          The proportion of its B2B business increased from 9 percent in 2017 to 43.3 percent in the first half of this year. By the end of 2017, its B2B business had covered 48,000 pharmacies, and the repurchase rate of its B2B pharmacies was up to 66.5 percent.

          Top
          BACK TO THE TOP
          English
          Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
          License for publishing multimedia online 0108263

          Registration Number: 130349
          FOLLOW US
          CLOSE
           
          主站蜘蛛池模板: 免费黄色福利| 中文字幕午夜福利片午夜福利片97| 美女一区二区三区亚洲麻豆| 国产午夜精品一区二区三| 蜜臀91精品国产高清在线| 五月丁香啪啪| 日本A级视频在线播放| 亚洲综合在线日韩av| 91麻豆国产视频| 国产av无码专区亚洲awww| 男女性高爱潮免费网站| 思思久99久女女精品| 国产一区二区三区色成人| 色哟哟www网站入口成人学校| 日本一区二区三区18岁| 无码欧亚熟妇人妻AV在线外遇| 成人一区二区三区在线午夜| 欧美喷潮最猛视频| 日韩精品少妇无码受不了| 91丝袜美腿高跟国产老师在线| 精品无码一区二区三区爱欲| 国产精品一区二区黄色片| 亚洲欧洲日韩国内高清| 欧美肥老太牲交大战| 欧美喷潮最猛视频| 国产男生午夜福利免费网站| 国产精品福利视频导航| 91久久天天躁狠狠躁夜夜| 欧美嫩交一区二区三区| 日本欧美大码a在线观看| 国产成人1024精品免费| 蜜桃av无码免费看永久| 真人无码作爱免费视频| 人妻无码ΑV中文字幕久久琪琪布 国产乱人伦AV在线麻豆A | 又大又长粗又爽又黄少妇毛片| 久操线在视频在线观看| 日日躁狠狠躁狠狠爱| 又湿又黄裸乳漫画无遮挡网站| 国产一区二区三区的视频| 377P欧洲日本亚洲大胆| 亚洲av综合av一区|